Friday 6 November 2026
Export CHE’s income statement to Excel — free account
Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
533.55
15.09
−2.75%
Follow CHE
Alert me
Chemed Corporation (CHE) revenue by segment, product and region
Where the money comes from and where it goes
| VITAS | 1,630 | 64.43% |
|---|---|---|
| Roto-Rooter | 900 | 35.57% |
| Gross margin | 32.54% | |
| Operating margin | 13.37% | |
| Pre-tax margin | 14.06% |
Revenue by segment $m
| Line | FY2025 | FY2024 | FY2023 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| VITAS | 1,630 64.43% | 1,531 62.97% | 1,315 58.08% | 1,148 68.89% | 1,123 71.24% | 1,116 72.28% | 1,064 73.08% | 1,045 73.95% | 1,067 74.62% | 986 72.74% |
| Roto-Rooter | 900 35.57% | 900 37.03% | 949 41.92% | 518 31.11% | 454 28.76% | 428 27.72% | 392 26.92% | 368 26.05% | 363 25.38% | 370 27.26% |
| Revenue | 2,530 | 2,431 | 2,264 | 1,667 | 1,577 | 1,543 | 1,456 | 1,413 | 1,430 | 1,356 |
Operating income by segment $m, and margin
Operating figures as reported in each quarter’s results release or filing
| Figure | Quarter | Latest | A year before | Change |
|---|---|---|---|---|
| Admissions | Q3 FY2026 | 19.0K | 17.7K | +7.23% |
| Average daily census | Q3 FY2026 | 24.4K | 22.3K | +9.41% |
| Average length of stay | Q2 FY2026 | 101.20 | — | — |
| Average revenue per patient per day | Q3 FY2026 | $209.11 | $205.08 | +1.97% |
| Continuous care average daily census | Q3 FY2026 | 214.00 | — | — |
| Continuous care days of care | Q3 FY2026 | 19.7K | 18.3K | +7.50% |
| Days of care | Q3 FY2026 | 2.2M | 2.1M | +9.41% |
| High acuity care reimbursement | Q3 FY2026 | $1,147.26 | $1,132.50 | +1.30% |
| High acuity days-of-care | Q3 FY2026 | 2.20% | 2.30% | — |
| Homecare average daily census | Q3 FY2026 | 20.3K | 18.3K | +11.04% |
| Homecare days of care | Q3 FY2026 | 1.9M | 1.7M | +11.05% |
| Inpatient average daily census | Q3 FY2026 | 331.00 | — | — |
| Inpatient days of care | Q3 FY2026 | 30.5K | 28.5K | +6.88% |
| Median length of stay | Q2 FY2026 | 16.00 | — | — |
| Nursing home average daily census | Q3 FY2026 | 3.4K | 3.4K | +1.13% |
| Nursing home days of care | Q3 FY2026 | 312.7K | 309.2K | +1.12% |
| Respite average daily census | Q3 FY2026 | 136.00 | 132.00 | +3.03% |
| Respite days of care | Q3 FY2026 | 12.5K | 12.2K | +2.61% |
| Routine homecare and respite average daily census | Q3 FY2026 | 23.9K | 21.8K | +9.46% |
| Routine homecare and respite days of care | Q3 FY2026 | 2.2M | 2.0M | +9.47% |
| Routine home care reimbursement | Q3 FY2026 | $187.69 | $183.44 | +2.32% |
| Total discharges | Q3 FY2026 | 18.4K | 17.3K | +6.21% |